Výsledky vyhledávání

Akademický článek

Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.

Autor: Minuesa G; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Albanese SK; Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Xie W; Structural Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Kazansky Y; Weill Cornell Medical College, Tri-Institutional MD-PhD Program, Rockefeller University and Sloan Kettering Institute, New York, NY, 10065, USA., Worroll D; Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, NY, 10065, USA., Chow A; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Schurer A; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Park SM; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Rotsides CZ; Chemical Biology Program, Sloan Kettering Institute and Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Taggart J; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Rizzi A; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medical College, New York, NY, 10065, USA., Naden LN; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chou T; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Gourkanti S; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Cappel D; Schrödinger GmbH, Q7, 23, 68161, Mannheim, Germany., Passarelli MC; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Weill Cornell Medical College, Tri-Institutional MD-PhD Program, Rockefeller University and Sloan Kettering Institute, New York, NY, 10065, USA., Fairchild L; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medical College, New York, NY, 10065, USA., Adura C; High-Throughput and Spectroscopy Resource Center, The Rockefeller University, New York, NY, 10065, USA., Glickman JF; High-Throughput and Spectroscopy Resource Center, The Rockefeller University, New York, NY, 10065, USA., Schulman J; Hematologic Oncology Tissue Bank, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Famulare C; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Patel M; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Eibl JK; Northern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada., Ross GM; Northern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada., Bhattacharya S; New York Structural Biology Center, NMR Group, New York, NY, 10027, USA., Tan DS; Chemical Biology Program, Sloan Kettering Institute and Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Leslie CS; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Beuming T; Schrödinger, Inc., 120 West 45th Street, New York, NY, 10036, USA., Patel DJ; Structural Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Goldgur Y; Structural Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Chodera JD; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Kharas MG; Molecular Pharmacology Program, Experimental Therapeutics Center and Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA. kharasm@mskcc.org.

Publikováno v: Nature communications [Nat Commun] 2019 Jun 19; Vol. 10 (1), pp. 2691. Date of Electronic Publication: 2019 Jun 19.

Zobrazit plný text záznamu

Akademický článek

Diastereoselective silylene transfer reactions to chiral enantiopure alkenes: effects of ligand size and substrate bias.

Autor: Rotsides CZ; Department of Chemistry, New York University, New York, NY 10003, USA. kwoerpel@nyu.edu., Woerpel KA

Publikováno v: Dalton transactions (Cambridge, England : 2003) [Dalton Trans] 2017 Jul 11; Vol. 46 (27), pp. 8763-8768.

Zobrazit plný text záznamu

Akademický článek

Diastereoselective synthesis of eight-membered-ring allenes from propargylic epoxides and aldehydes by silylene insertion into carbon-oxygen bonds.

Autor: Rotsides CZ; Department of Chemistry, New York University, 100 Washington Square East, New York, NY 10003 (USA)., Hu C, Woerpel KA

Publikováno v: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2013 Dec 02; Vol. 52 (49), pp. 13033-6. Date of Electronic Publication: 2013 Oct 09.

Zobrazit plný text záznamu

Akademický článek

RNA binding protein ZCCHC24 promotes tumorigenicity in triple-negative breast cancer.

Autor: Uchida Y; Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Kurimoto R; Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Chiba T; Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Matsushima T; Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Oda G; Department of Surgery, Breast Surgery, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Onishi I; Department of Comprehensive Pathology, Institute of Science Tokyo, Tokyo, 113-8510, Japan., Takeuchi Y; Division of Cancer Cell Biology, Kanazawa University, Kanazawa, 920-1192, Japan.; Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, 920-1192, Japan., Gotoh N; Division of Cancer Cell Biology, Kanazawa University, Kanazawa, 920-1192, Japan.; Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, 920-1192, Japan., Asahara H; Department of Systems Biomedicine, Institute of Science Tokyo, Tokyo, 113-8510, Japan. asahara.syst@tmd.ac.jp.; Department of Molecular and Cellular Biology, Scripps Research, La Jolla, CA, 92037, USA. asahara.syst@tmd.ac.jp.

Publikováno v: EMBO reports [EMBO Rep] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Zobrazit plný text záznamu